Suchergebnisse - "Jullien, Maxime"

PubPharm (48)

1

Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult : A case report

enthalten in: Skin health and disease | 2024

von Peterlin, P. | Bonnelye, J. | Garnier, A. | +10

2

Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia : Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome

enthalten in: Cancers | 2024

von Antier, C. | Jullien, M. | Tessoulin, B. | +6

3

Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide

enthalten in: American journal of hematology | 2024

von Jullien, M. | Guillaume, T. | Le Bourgeois, A. | +19

4

Phase I study of zoledronic acid combined with escalated doses of interleukine‐2 for early in vivo generation of Vγ9Vδ2 T‐cells after haploidentical stem cell transplant with posttransplant cyclophosphamide

enthalten in: American Journal of Hematology | 2024

von Jullien, M. | Guillaume, T. | Le Bourgeois, A. | +19

5

Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult : A case report

enthalten in: Skin Health and Disease | 2024

von Peterlin, P. | Bonnelye, J. | Garnier, A. | +10

6

Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients

enthalten in: EJHaem | 2023

von Peterlin, P. | Béné, M. | Jullien, M. | +6

7

Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study) : a single-centre, single-arm, phase 1 trial

enthalten in: EClinicalMedicine | 2023

von Peterlin, P. | Garnier, A. | Le Bourgeois, A. | +10

8

Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival

enthalten in: Bone marrow transplantation | 2023

von Jullien, M. | Le Bourgeois, A. | Peterlin, P. | +4

9

Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation

enthalten in: Cancers | 2023

von Legrand, N. | Salameh, P. | Jullien, M. | +9

10

Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplant

enthalten in: Clinical and translational medicine | 2023

von Bourgeois, A. | Jullien, M. | Garnier, A. | +4

1
2
3
4
5
Nächster »
[5]